OverviewChartNewsTraderScreen

Soc. Generale Knock-Out AMGN/  DE000SB0ZNK5  /

Frankfurt Zert./SG
5/20/2024  10:54:06 AM Chg.0.000 Bid5/20/2024 Ask5/20/2024 Underlying Strike price Expiration date Option type
9.020EUR 0.00% 9.020
Bid Size: 2,000		 9.140
Ask Size: 2,000		 Amgen Inc 214.2156 USD 12/31/2078 Call
TeleTrader 5/16 FDA approves Amgen's small cell lung cancer drug
GlobeNewswire 5/16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 5/15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire 5/14 Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier
GlobeNewswire 5/14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 5/13 TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/9 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 5/9 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 5/8 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
TeleTrader 5/8 US closes flat to higher with more earnings on the horizon
GlobeNewswire 5/8 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
TeleTrader 5/3 US closes higher after softer-than-expected jobs print
TeleTrader 5/3 Wall Street surges on open as jobs report sparks rate cut hopes
TeleTrader 5/3 Amgen soars 14% on positive weight-loss drug data
TeleTrader 5/2 Amgen Q1 revenue jumps 22% to $7.4 billion
TeleTrader 5/2 US surges at close as traders weigh Fed remarks
TeleTrader 5/2 US opens higher, Dow jumps 240 points
GlobeNewswire 5/2 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...
TeleTrader 5/2 US higher premarket after Fed's decision
GlobeNewswire 5/1 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 5/1 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 4/30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...
GlobeNewswire 4/24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...